CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer

Triple-negative breast cancer (TNBC) is a high medical need disease with limited treatment options. CD8+ T cell-mediated immunotherapy may represent an attractive approach to address TNBC. The objectives of this study were to assess the expression of CXorf61 in TNBCs and healthy tissues and to evalu...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Paret, Claudia, Simon, Petra, Vormbrock, Kirsten, Bender, Christian, Kölsch, Anne, Breitkreuz, Andrea, Yildiz, Özlem, Omokoko, Tana, Hubich-Rau, Stefanie, Hartmann, Christoph, Häcker, Sabine, Wagner, Meike, Roldan, Diana Barea, Selmi, Abderaouf, Türeci, Özlem, Sahin, Ugur
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2015
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4694836/
https://ncbi.nlm.nih.gov/pubmed/26327325
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg